These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 33707884)
1. Presepsin: A Promising Biomarker for Sepsis. Azim A Indian J Crit Care Med; 2021 Feb; 25(2):117-118. PubMed ID: 33707884 [TBL] [Abstract][Full Text] [Related]
2. Soluble CD14 subtype (sCD14-ST) presepsin in premature and full term critically ill newborns with sepsis and SIRS. Mussap M; Puxeddu E; Puddu M; Ottonello G; Coghe F; Comite P; Cibecchini F; Fanos V Clin Chim Acta; 2015 Dec; 451(Pt A):65-70. PubMed ID: 26232159 [TBL] [Abstract][Full Text] [Related]
3. Is There a Role of Presepsin as a Novel Biomarker in Pediatric Sepsis? Khera D; Toteja N; Singh S; Singh S; Kumar P; Sharma P; Singh K Indian J Crit Care Med; 2022 Jun; 26(6):712-716. PubMed ID: 35836633 [TBL] [Abstract][Full Text] [Related]
4. Role of Presepsin for the Diagnosis of Sepsis and ICU Mortality: A Prospective Controlled Study. Abdelshafey EE; Nasa P; Elgohary AE; Khalil MF; Rashwan MA; Ghezala HB; Tayar AA Indian J Crit Care Med; 2021 Feb; 25(2):153-157. PubMed ID: 33707892 [TBL] [Abstract][Full Text] [Related]
5. Presepsin (soluble CD14 subtype) and procalcitonin levels for mortality prediction in sepsis: data from the Albumin Italian Outcome Sepsis trial. Masson S; Caironi P; Spanuth E; Thomae R; Panigada M; Sangiorgi G; Fumagalli R; Mauri T; Isgrò S; Fanizza C; Romero M; Tognoni G; Latini R; Gattinoni L; Crit Care; 2014 Jan; 18(1):R6. PubMed ID: 24393424 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic and prognostic value of presepsin in the management of sepsis in the emergency department: a multicenter prospective study. Ulla M; Pizzolato E; Lucchiari M; Loiacono M; Soardo F; Forno D; Morello F; Lupia E; Moiraghi C; Mengozzi G; Battista S Crit Care; 2013 Jul; 17(4):R168. PubMed ID: 23899120 [TBL] [Abstract][Full Text] [Related]
8. Comparison of Diagnostic Accuracy of Presepsin and Procalcitonin for Sepsis in Critically Ill Patients: A Prospective Observational Study. Roy S; Kothari N; Sharma A; Goyal S; Sankanagoudar S; Bhatia PK; Sharma P Indian J Crit Care Med; 2023 Apr; 27(4):289-293. PubMed ID: 37378028 [TBL] [Abstract][Full Text] [Related]
9. Soluble CD14 subtype (sCD14-ST) presepsin in critically ill preterm newborns: preliminary reference ranges. Mussap M; Puxeddu E; Burrai P; Noto A; Cibecchini F; Testa M; Puddu M; Ottonello G; Dessì A; Irmesi R; Gassa ED; Fanni C; Fanos V J Matern Fetal Neonatal Med; 2012 Oct; 25(Suppl 5):51-3. PubMed ID: 23025769 [TBL] [Abstract][Full Text] [Related]
10. Presepsin: Hope in the Quest for the Holy Grail. Samprathi A; Samprathi M; Reddy M Indian J Crit Care Med; 2022 Jun; 26(6):664-666. PubMed ID: 35836630 [No Abstract] [Full Text] [Related]
11. [Usefulness of sCD14-ST in the diagnosis of sepsis in patient with renal failure]. Galeano D; Zanoli L; Fatuzzo P; Granata A G Ital Nefrol; 2016; 33(2):. PubMed ID: 27067215 [TBL] [Abstract][Full Text] [Related]
12. Presepsin as a biomarker in perioperative medicine. Handke J; Piazza O; Larmann J; Tesoro S; De Robertis E Minerva Anestesiol; 2020 Jul; 86(7):768-776. PubMed ID: 32068982 [TBL] [Abstract][Full Text] [Related]
13. Antibody-mediated soluble CD14 stabilization prevents agitation-induced increases in presepsin levels in blood component specimens. Morino G; Takahashi G; Kan S; Inoue Y; Sato K; Shirakawa K Biotechniques; 2021 Mar; 70(3):160-166. PubMed ID: 33512240 [TBL] [Abstract][Full Text] [Related]
14. The limits and potentials of presepsin in orthopaedic surgery: state of the art and future directions. Vicenti G; Solarino G; Bizzoca D; Caringella N; Nappi VS; Moretti L; Belluati A; Moretti B J Biol Regul Homeost Agents; 2020; 34(4 Suppl. 3):259-262. Congress of the Italian Orthopaedic Research Society. PubMed ID: 33261287 [TBL] [Abstract][Full Text] [Related]
15. Circulating presepsin (soluble CD14 subtype) as a marker of host response in patients with severe sepsis or septic shock: data from the multicenter, randomized ALBIOS trial. Masson S; Caironi P; Fanizza C; Thomae R; Bernasconi R; Noto A; Oggioni R; Pasetti GS; Romero M; Tognoni G; Latini R; Gattinoni L Intensive Care Med; 2015 Jan; 41(1):12-20. PubMed ID: 25319385 [TBL] [Abstract][Full Text] [Related]
16. Usefulness of presepsin (sCD14 subtype) measurements as a new marker for the diagnosis and prediction of disease severity of sepsis in the Korean population. Kweon OJ; Choi JH; Park SK; Park AJ J Crit Care; 2014 Dec; 29(6):965-70. PubMed ID: 25042676 [TBL] [Abstract][Full Text] [Related]
17. Can presepsin uniformly respond to various pathogens? - an in vitro assay of new sepsis marker. Koizumi Y; Sakanashi D; Mohri T; Watanabe H; Shiota A; Asai N; Kato H; Hagihara M; Murotani K; Yamagishi Y; Suematsu H; Mikamo H BMC Immunol; 2020 Jun; 21(1):33. PubMed ID: 32503419 [TBL] [Abstract][Full Text] [Related]
18. Utility of sTREM-1 and Presepsin (sCD14-ST) as Diagnostic and Prognostic Markers of Sepsis. Chen M; Zhu Y Clin Lab; 2020 Apr; 66(4):. PubMed ID: 32255294 [TBL] [Abstract][Full Text] [Related]
19. Development of a newly immunoassay specific for mouse presepsin (sCD14-ST). Takahashi G; Hoshikawa K; Suzuki R; Sato K; Hoshi S; Yoshinao D; Shirakawa K Sci Rep; 2022 Dec; 12(1):21724. PubMed ID: 36522357 [TBL] [Abstract][Full Text] [Related]
20. Soluble CD14 subtype (sCD14-ST) as biomarker in neonatal early-onset sepsis and late-onset sepsis: a systematic review and meta-analysis. van Maldeghem I; Nusman CM; Visser DH BMC Immunol; 2019 Jun; 20(1):17. PubMed ID: 31159729 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]